EUDA Health Holdings Warrant
EUDAW
11 hedge funds and large institutions have $146K invested in EUDA Health Holdings Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
51% more capital invested
Capital invested by funds: $96.7K → $146K (+$49.6K)
0% more funds holding
Funds holding: 11 → 11 (0)
0.21% less ownership
Funds ownership: 6.28% → 6.07% (-0.21%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.13K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$146 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$1.43K |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$164 |
EUDAW Hedge Fund Activity: Q4 2023 in Review
11 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q4 2023, worth a combined $146K — up 51% from $96.7K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new EUDAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.13K. The largest seller was Yakira Capital Management, cutting an estimated $1.43K.
- 11 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $146K of EUDA Health Holdings Warrant stock for Q4 2023, up 51% quarter-over-quarter.
- 1 fund opened new EUDA Health Holdings Warrant positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest EUDA Health Holdings Warrant buyer in Q4 2023 was Citadel Advisors, an estimated $1.13K added.
- The largest EUDA Health Holdings Warrant seller in Q4 2023 was Yakira Capital Management, an estimated $1.43K sold.
Based on aggregated 13F filings for Q4 2023.